ABSTRACT
Staphylococcus epidermidis is a major nosocomial pathogen with a remarkable ability to persist on indwelling medical devices through biofilm formation. Nevertheless, it remains intriguing how this process is efficiently achieved under the host’s harsh conditions, where the availability of nutrients, such as essential metals, is scarce. Following our previous identification of two iron-regulated loci putatively involved in iron transport, hts and fhuC, we assessed here their individual contribution to both bacterial physiology and interaction with host immune cells. Single deletions of the hts and fhuC loci led to marked changes in the cell iron content, which were partly detrimental for planktonic growth and strongly affected biofilm formation under iron-restricted conditions. Deletion of each of these two loci did not lead to major changes in S. epidermidis survival within human macrophages or in an ex vivo human blood model of bloodstream infection. However, the lack of either hts or fhuC loci significantly impaired bacterial survival in vivo in a murine model of bacteremia. Collectively, this study establishes, for the first time, the pivotal role of the iron-regulated loci hts and fhuC in S. epidermidis biofilm formation and survival within the host, providing relevant information for the development of new targeted therapeutics against this pathogen.
IMPORTANCE Staphylococcus epidermidis is one of the most important nosocomial pathogens and a major cause of central line-associated bloodstream infections. Once in the bloodstream, this bacterium must surpass severe iron restriction in order to survive and establish infection. Surprisingly, very little is known about the iron acquisition mechanisms in this species. This study represents the first report on the involvement of the S. epidermidis iron-regulated loci hts and fhuC in biofilm formation under host relevant conditions and, most importantly, in survival within the host. Ultimately, these findings highlight iron acquisition and these loci in particular, as potential targets for future therapeutic strategies against biofilm-associated S. epidermidis infections.
KEYWORDS: biofilms, innate immunity, iron
INTRODUCTION
Healthcare-associated infections have become a major threat to public health worldwide (1). Staphylococcus epidermidis has emerged as a major cause of nosocomial infections and belongs to the most common etiologic agents of infections associated with the use of indwelling medical devices and implants, particularly catheters and prosthetic joints (2). Furthermore, there has been a global spread of multidrug-resistant S. epidermidis lineages (3), which has led to an increased shortage of therapeutic options for these kinds of infections.
As a major cause of device-associated bloodstream infections (4), S. epidermidis must have the ability to thrive in the severely iron-restricted bloodstream (5). Surprisingly, very little is known about the iron acquisition mechanisms of this species, which might be attributable, at least in part, to the inherent challenges of genetically manipulating staphylococci, particularly S. epidermidis (6). Iron acquisition has been suggested as a key process in bacterial pathogenicity, since pathogens face severe restriction in the availability of this metal, a phenomenon usually referred to as “nutritional immunity” (7). To surpass iron limitation, bacteria must have dedicated mechanisms to acquire this important metal and use it for their own cellular functions (8). One common strategy employed by bacteria to meet their iron requirements is to express specific surface receptors coupled to specialized transport systems that allow the translocation of iron across the cytoplasmic membrane. These include ATP-binding cassette (ABC) transporters, which mediate the import of iron, either in its ionic form or coupled to host-derived (e.g., transferrin and heme) (9) or bacteria-derived molecules (e.g., siderophores) (10). The study of iron acquisition mechanisms in staphylococci has been mostly focused on S. aureus (11–17), which has led to the identification and characterization of two siderophores belonging to the carboxylate family, staphyloferrin A (13, 14) and staphyloferrin B (15, 17), as well as their cognate transporters HtsABC and SirABC, respectively (11, 18).
The actual contribution of iron acquisition to S. epidermidis virulence has not been established to date. In this study, we establish the involvement of two recently identified iron-regulated loci (hts and fhuC, which together are predicted to encode an iron ABC transporter system) in S. epidermidis virulence, as demonstrated by their contribution to biofilm formation and survival within the host.
RESULTS
FhuC is critical for S. epidermidis to acquire iron.
We have previously identified two iron-regulated loci encoding components of an ABC transporter putatively involved in iron transport (19), which are well conserved across different S. epidermidis strains (Fig. S1). The B4U56_03565-03575 locus (henceforth called htsABC) is located immediately adjacent to the sfaABCD cluster, a putative siderophore biosynthetic pathway, and encodes two membrane permeases and one substrate-binding protein (Fig. 1a). Interestingly, this locus lacks the gene encoding the ATP-binding protein of a classical ABC transporter, something that has also been reported in S. aureus (13). Based on our previous identification of different iron-regulated genes (19), we hypothesized that the B4U56_10485 locus (henceforth called fhuC) encodes the missing protein (Fig. 1b). To confirm the involvement of these loci in iron acquisition, we deleted each locus in S. epidermidis 1457 following an allelic replacement strategy. Surprisingly, while a remarkable reduction in the iron cell content of the ΔfhuC strain was detected, deletion of hts led to a minor increase, although not statistically significant, in the iron cell content (Fig. 1c). Additionally, deletion of either hts or fhuC resulted in a growth defect under iron-restricted conditions, which was more evident between 6 and 8 h of growth. Nevertheless, both mutants were able to replicate under these conditions, achieving a cell density equivalent to the wild-type (wt) strain after 24 h (Fig. 1d). Since deletion of hts led to a marked rise in the cell iron content, we next studied the interplay among different iron acquisition systems at a transcriptional level. While siderophore overproduction by the Δhts mutant was not apparent (Fig. S2), transcription analysis by quantitative real-time PCR (qPCR) of cells grown under iron-restricted conditions demonstrated that the mRNA levels of sfaB (putative siderophore synthetase) were significantly increased in this strain (Fig. 1e). This gene belongs to an iron-regulated locus (sfaABCD) that we recently characterized and demonstrated to play an important role in iron acquisition and bacterial survival within the host (20). Additionally, a slight but not significant increase in fhuC mRNA levels was detected in this mutant (Fig. 1e). On the other hand, ΔfhuC cells exhibited significant higher mRNA levels of both sfaB and htsC genes relative to wt (Fig. 1e). By providing the missing loci in trans (phts and pfhuC), the aforementioned effects could be fully/partly reversed (complementation with expression of fhuC in trans did not reverse the growth defect exhibited by ΔfhuC; Fig. S3a to c), strongly suggesting that the differences observed are attributable to the deletion of these loci.
FIG 1.
Deletion of hts or fhuC has different outcomes in the iron cell content but not in the growth of S. epidermidis under iron-restricted conditions. (a, b) Genomic organization of the htsABC (a) and fhuC (b) loci in S. epidermidis, which encode putative components of iron ABC transporters. Assignments are based on the annotated genomes of S. epidermidis 1457 (accession number: CP020463). Open reading frames are indicated by arrows, which show the direction of transcription. Predicted transcriptional start sites are indicated by bent arrows. Putative Fur boxes are shown as gray boxes, and alignments with a consensus sequence are provided below. (c) Analysis of the cellular iron content by atomic absorption spectroscopy (N = 4). (d) Strains were allowed to grow for 24 h at 37°C, 120 rpm in CDM(Fe−), and growth was monitored as means of the optical density at 640 nm (OD640) (N = 3 to 4). (e) Transcription of iron acquisition-associated genes after culture in CDM(Fe−) for 24 h. Fold change data were calculated according to Pfaffl method and log transformed (Log2). Values above and below 0 indicate up- and downregulation of transcription, respectively, relative to wild type (wt) (N = 3). (c to e) Two-tailed t test (c) or two-way analysis of variance (ANOVA) (d, e). The bars (c, e) and symbols (d) represent the mean of biological replicates and the error bars represent the standard error of the mean (SEM). ns, not significant; *, P < 0.05 versus wt; **, P < 0.01 versus wt.
Collectively, while these findings are compatible with a transcriptional compensation in response to disruption of specific iron acquisition pathways, it is worth mentioning that the effect on the iron content of these two mutants was strikingly distinct. Overall, our observations suggest a strong transcriptional interplay among different iron acquisition systems, with fhuC playing a more prominent role in the maintenance of iron homeostasis in S. epidermidis.
S. epidermidis relies on iron acquisition through the Hts-FhuC transporter to form biofilms.
To assess the contribution of iron acquisition to biofilm formation by S. epidermidis, recognized as its major virulence factor, we tested our mutant strains for their ability to form biofilms under different iron availability conditions. When grown in the iron-rich culture medium TSB (Fig. 2a), none of the mutant strains exhibited impaired biofilm formation ability. However, deletion of either hts or fhuC loci proved to be detrimental for biofilm formation under conditions of iron restriction (Fig. 2b). This effect could be partially or fully reversed either by providing the missing loci in trans (Fig. 2c) or by supplementing the iron-restricted medium with iron chloride (Fig. 2d). Biofilms formed under iron-restricted conditions were further examined through confocal microscopy for the assessment of biofilm organization and the polysaccharide intercellular adhesin (PIA), also known as poly-N-acetyl-β-(1-6)-glucosamine (PIA/PNAG) content in the biofilm matrix (Fig. 2e). While wt formed thick biofilms containing a high density of cells widespread across the surface and large amounts of PIA/PNAG, Δhts and ΔfhuC formed sparse biofilms mostly composed of cell clusters embedded in small amounts of PIA/PNAG. Gene complementation reversed the biofilm phenotype of all mutant strains (Fig. 2f). Taken together, our data reveal that S. epidermidis relies on the Hts-FhuC transporter to meet the iron requirements for biofilm formation when the availability of this metal is scarce.
FIG 2.
Iron acquisition through the Hts-FhuC transporter is key for biofilm formation in low-iron environments. (a to c) The biofilm formation ability of each strain was evaluated in TSB (a), iron-restricted chemically modified medium (CDM[Fe−]) (b, c), and iron-enriched chemically modified medium (CDM[Fe+]) (c). The cells were allowed to grow statically for 24 h at 37°C on 96-well microplates. Biofilm quantification was performed through crystal violet staining (N = 3 to 5). (c) Confocal laser scanning microscopy (CLSM) analysis of biofilms formed under iron-restricted conditions (CDM[Fe−]). Biofilms were allowed to grow on an 8-well chamber slide system in CDM(Fe−) at 37°C for 24 h. CLSM was used for biofilm structure analysis and PIA/PNAG production after appropriate staining with DAPI (4′,6-diamidino-2-phenylindole) (depicted in blue) and WGA-Texas Red (depicted in red). Representative images of Z-stack projections from two independent experiments are shown. Bar = 100 μm for 10× and 20 μm for 40×. ****, P < 0.0001 versus wt. (a to d) One-way ANOVA with Dunnett’s multiple-comparison test. The bars represent the mean of biological replicates, and the error bars represent the standard deviation.
The lack of the Hts-FhuC transporter does not change survival of S. epidermidis inside human macrophages.
Macrophages are crucial players in the innate immune response against staphylococcal infections, as they phagocytose invading bacteria and expose them to a plethora of antimicrobial compounds (21). In addition, these cells are at the crossroads of innate immunity and iron metabolism by regulating iron homeostasis in response to infection (22). While biofilm formation has been shown to protect S. epidermidis from phagocytosis (23) and the action of antimicrobial peptides (24), the fate of S. epidermidis cells once phagocytosed is poorly understood. Our previous findings on the importance of iron availability for S. epidermidis growth and biofilm formation (19) led us to hypothesize that the absence of specific iron acquisition systems may affect the survival of this bacterium inside phagocytic cells. To that end, we first studied the ability of S. epidermidis to survive within macrophages using the murine cell line RAW264.7 and a gentamicin protection assay (Fig. 3a). While these macrophages were able to control intracellular replication up to 12 h of infection, some level of bacterial proliferation became apparent at 24 h postinfection, although not statistically significant (Fig. 3b). Even though previous studies have reported intracellular persistence of S. epidermidis (25–27), replication within macrophages was an unprecedented finding. To further assess whether S. epidermidis could grow intracellularly in macrophages, we replicated our macrophage infection assays using human monocyte-derived macrophages (hMDMs) with different polarization phenotypes (M1- and M2-like macrophages). Unlike RAW264.7 cells, hMDMs cleared phagocytosed S. epidermidis, with no CFU detected in both M1- and M2-like hMDM cultures at 24 h postinfection. Of note, no significant differences were found in the number of bacterial cells residing intracellularly at 2 h postinfection relative to wt, with the exception of a numerical increase in ΔfhuC cells in M2-like macrophages (Fig. 3c).
FIG 3.
The iron-regulated loci hts and fhuC do not contribute to the interaction between S. epidermidis and phagocytic cells. (a) Schematic diagram of the gentamicin protection assays used in this study. Macrophages (murine RAW264.7 or human monocyte-derived macrophages [hMDMs]) were infected with S. epidermidis as described in Materials and Methods. Bacterial cells were recovered from the lysed macrophages, plated on TSA and CFU counted after 1 to 2 days at 37°C. (b) Gentamicin protection assays using murine RAW264.7 macrophages. Data are represented as mean ± SD of the fold change in CFU (relative to 0 h postinfection) for biological replicates (N = 3). (c) Gentamicin protection assays using hMDMs. Each point represents the CFU fold change (2 versus 0 h postinfection) obtained in one experiment with a single donor and lines represent the median from biological replicates (N = 3 donors). Values above and below 0 indicate bacterial replication and clearance, respectively. (b, c) Values above and below 0 indicate bacterial replication and clearance, respectively. No significant differences were detected using one-way ANOVA with Dunnett’s multiple-comparison test. GM-CSF, granulocyte macrophage colony-stimulating factor; M-CSF, macrophage colony-stimulating factor.
Hts/FhuC transporter is required for S. epidermidis survival within the host.
As S. epidermidis is a major pathogen causing bloodstream infections originating from indwelling medical device contamination (4), we hypothesized that iron acquisition provides a fitness advantage to this bacterium upon exposure to human blood. However, no significant changes relative to wt strain were registered, at both 2 and 4 h after exposure to human blood (Fig. S4). Nevertheless, when using a murine in vivo model of S. epidermidis bacteremia, we detected that mouse groups infected with either Δhts and ΔfhuC mutants exhibited significantly reduced bacterial loads in blood, liver, and kidneys at 6 h postinfection compared with the wt strain (Fig. 4). In addition, ΔfhuC-infected mice also displayed a significantly reduced bacterial burden in the spleen. Conclusively, our in vivo findings provide significant evidence for the involvement of Hts-FhuC-mediated iron acquisition in S. epidermidis survival within the host.
FIG 4.
S. epidermidis hts and fhuC mutants exhibit impaired survival within the host. BALB/c mice were infected intravenously with 5 × 108 CFU of S. epidermidis 1457 or its isogenic iron uptake (Δhts and ΔfhuC) mutants. Six hours after infection, the mice were euthanized; blood, liver, kidneys, and spleen were aseptically collected, weighed, and homogenized; and the bacterial burdens were determined by CFU counts. Each symbol represents one animal (N = 12/strain). Horizontal bars represent the mean from two pooled independent experiments. Significant differences were determined by one-way ANOVA with Dunnett’s multiple-comparison test. *, P < 0.05 versus wt; ***, P < 0.001 versus wt; ****, P < 0.0001 versus wt.
DISCUSSION
Unlike several other pathogens, the mechanisms behind iron acquisition in S. epidermidis remain largely unknown. Even though iron acquisition has been explored in more detail in the closely related species S. aureus, we have identified key differences between these two staphylococcal species that makes it difficult to directly translate findings from one species to another. First, S. aureus produces two different siderophores (staphyloferrins A and B) and expresses two transporters fully dedicated to their uptake (HtsABC and SirABC) (13, 14), whereas S. epidermidis has a single siderophore biosynthetic locus (19, 20). Second, genomic data available to date indicate that the S. aureus iron-regulated surface determinant (Isd), a dedicated system for acquisition of heme-bound iron (28, 29), is absent in S. epidermidis. Therefore, S. epidermidis seems to employ less complex mechanisms for iron acquisition, which may increase the relevance of each individual acquisition system for key virulence processes. This study represents a first approach to this hypothesis, with our focus being directed toward the iron-regulated loci hts and fhuC, which are predicted to encode the different components of an ABC transporter.
Specifically, we demonstrated the involvement of these loci in iron acquisition, as deletion of either hts or fhuC loci had a noticeable impact in the cell iron content (Δhts = high iron cell content; ΔfhuC = low iron cell content). Analysis of transcript levels of iron acquisition-related genes revealed an upregulation of sfaB (putative siderophore synthetase) in both mutants when cultured under iron restriction. Furthermore, we detected a significant increase in htsC transcript levels in ΔfhuC mutant cells. However, none of these transcriptional changes were sufficient to restore the iron cell content of ΔfhuC mutant to wt levels, which indicates that the ATPase FhuC plays a central role in iron acquisition by S. epidermidis. Moreover, our results support some degree of redundancy among other unidentified iron acquisition systems, as none of the deletions created led to either complete depletion of the cell iron stores or significant changes in other parameters, such as bacterial survival in macrophages or human blood. This potential redundancy has been demonstrated in other microorganisms (30, 31), and our data are highly indicative that a similar process may also occur in S. epidermidis. After establishing the role of these loci in iron acquisition and taking into account our previous findings supporting the pivotal role of iron in S. epidermidis biofilm formation, we hypothesized that the lack of either hts or fhuC would be detrimental for biofilm formation. According to our results, S. epidermidis relies on iron acquisition through the Hts-FhuC transporter to form biofilms under iron-restricted conditions. The association between iron acquisition and biofilm formation has been established in some pathogens (32), but it is still poorly explored in S. epidermidis. Identifying new molecular factors involved in biofilm formation is key in the context of S. epidermidis infections, as biofilm formation is regarded as the major virulent trait exhibited by this pathogen.
Lastly, this study provides important in vivo data of the first iron acquisition mutants ever created in S. epidermidis. Although lack of either hts or fhuC did not significantly affect the bacterial survival within murine macrophage RAW264.7 cells or human macrophages, we demonstrated in a murine model of bacteremia that the Hts-FhuC iron transporter plays a significant role in bacterial survival in vivo. The absence of cytokine help may explain the inability of RAW264.7 cells alone to control S. epidermidis intracellular replication in vitro as interferon-γ was previously shown to limit S. epidermidis intracellular persistence in murine macrophages (25). Moreover, RAW264.7 cells do not express apoptotic speck-like protein with a caspase activation and recruiting domain and thus have no caspase-1 inflammasome activity, secreting lower mature interleukin 1β (IL-1β) levels (33). This is an important mechanism that participates in staphylococcal killing by macrophages (34). Additionally, our results indicate that M1-type polarization makes macrophages less permissive for S. epidermidis growth than M2-type polarization in line with previous observations with S. aureus (35). In the infected mouse groups, no major organ-dependent variation in the bacterial loads was observed for the mutants, suggesting that this iron acquisition mechanism does not play a niche-specific role, at least in the organs tested. The concept of iron acquisition-related molecules displaying a niche-specific role has been recently introduced by Perry et al., based on the observation that S. aureus siderophores were heterogeneously distributed across abscesses in different tissues (12). However, and as discussed above, S. epidermidis iron acquisition mechanisms are not as diverse as those expressed by S. aureus, and thus it seems they may play an equal role regardless of host location.
Collectively, this study represents the most thorough analysis to date of iron acquisition in S. epidermidis. The iron ABC transporter Hts-FhuC proved to be essential for bacterial survival in the iron-deprived environments, like those found within the host, since deletion of either hts or fhuC loci proved to be detrimental for two key virulence processes: biofilm formation and bacterial survival in vivo. Ultimately, this work emphasizes the potential of the Hts-FhuC iron transporter as a potential target for new therapeutic strategies against biofilm-associated S. epidermidis infections.
MATERIALS AND METHODS
Strains, plasmids, antibiotics, and culture media.
Bacterial strains and plasmids used in this study are described in Table S1. Unless otherwise noted, strains were cultured at 37°C. For genetic manipulations, Escherichia coli was grown in lysogeny broth (LB; 10 g/liter tryptone, 5 g/liter yeast extract, 10 g/liter NaCl). Staphylococci were grown in TSB (BD Diagnostic Systems, Heidelberg, Germany). Solid media were prepared by adding 1.5% (wt/vol) agar (BD) to the culture medium. For selection of plasmids and recombinant alleles, antibiotics (Sigma-Aldrich, St. Louis, MO) were added to the medium at the following concentrations: ampicillin (100 μg/mL) for E. coli selection and plasmid maintenance; trimethoprim (30 μg/mL), spectinomycin (150 μg/mL), and erythromycin (10 μg/mL) for staphylococci selection; and chloramphenicol (10 μg/mL) for staphylococcal plasmid maintenance. Iron restriction was achieved by slightly modifying a chemically defined medium (CDM) recipe (36), in which its original iron source (ammonium iron [II] sulfate) was omitted. This culture medium is henceforth referred to as CDM(Fe−). Iron-enriched conditions were achieved either by using TSB or by supplementing CDM(Fe−) with 10 μM FeCl3 [CDM(Fe+)]. All solutions and media were made with water purified through a Milli-Q water purification system (Millipore, Burlington, MA).
Genetic manipulations.
Standard DNA manipulations were performed essentially as described by Sambrook et al. (37). Restriction endonucleases were purchased from New England Biolabs, Inc. (Frankfurt, Germany) or Thermo Scientific Inc. (Waltham, MA). Phusion high-fidelity DNA polymerase and DyNAzyme II DNA polymerase were purchased from Thermo Scientific Inc. Plasmid DNA was purified using the QIAprep spin miniprep kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. For plasmid purification from staphylococci, the resuspension buffer provided with the plasmid isolation kit was supplemented with 25 U of lysostaphin (Sigma-Aldrich), and the cell suspension was incubated for 30 min at 37°C. Oligonucleotides and DNA sequencing services were purchased from Eurofins Genomics (Ebersberg, Germany).
Construction of mutant strains.
An allelic replacement strategy was used for the construction of four deletion mutants in S. epidermidis 1457 strain. The list of primers used is shown in Table S2. For each mutant, two ∼1-kb fragments flanking regions up- and downstream of the coding region to be deleted and an antibiotic resistance cassette were amplified using Phusion high-fidelity DNA polymerase (Thermo Fisher Scientific Inc.). Amplicons were ligated and cloned into plasmid pBASE6 (38) using (i) a Gibson assembly cloning kit (New England Biolabs, Inc.), according to the manufacturer’s instructions or (ii) circular polymerase extension cloning (CPEC), as previously described (39). The resulting plasmids were introduced by electroporation, first into S. aureus RN4220 and then into S. epidermidis 1457Δagr or 1457-M12. Next, using phage A6C, plasmids were introduced into S. epidermidis 1457. Selection of mutants was performed essentially as described (40). Correctness of the chromosomal mutations was verified using PCR with primers that bind to genetic regions not involved in the mutagenesis process, and afterwards the respective amplicons were sequenced. For complementation, DNA fragments containing the deleted coding sequences and their anticipated natural promoters were amplified and cloned into plasmid pRB473, as described above. Plasmids were introduced by electroporation first into S. aureus PS187ΔΔ and then into S. epidermidis 1457 mutant strains using phage Φ187, following a previously published protocol (41). All wild-type and mutated alleles were confirmed for their sequence correctness by DNA sequencing.
Quantification of bacterial iron content.
Two-mL of cultures grown overnight in TSB (BD) were harvested by centrifugation at 5,000 × g for 10 min at 4°C. The cells were washed twice in ultrapure water and diluted into CDM(Fe−) to an optical density at 640 nm (OD640) of 0.025 (∼107 CFU/mL) in disposable plastic tubes. Chloramphenicol was added to the growth medium of the plasmid-bearing strains for plasmid maintenance. Cultures were incubated at 37°C, 120 rpm (ES-20 Shaker-Incubator) for 24 h. Afterwards, the cultures were harvested by centrifugation at 5,000 × g, for 10 min at 4°C, and the pellet was washed thrice with metal-free ultrapure water to remove salts. Samples were then assayed for total iron content through atomic absorption spectrophotometry. Homogenized bacterial samples dispersed in ultrapure water were placed in previously weighed Teflon vessels (MS105, Mettler Toledo, Greifensee, Switzerland) and then dried in an oven at 90°C (P Selecta, Barcelona, Spain) until three reproducible weight values were obtained. Microwave-assisted digestion of samples was performed by adding 10 mL of Suprapur nitric acid 65% (vol/vol) (Merck) to each vessel containing the dried and accurately weighed samples. The microwave-assisted digestion proceeded accordingly with the steps described in Table S3, using a Mars-X 1,500-W microwave accelerated reaction system for digestion and extraction (CEM Corp., Matthews, NC), configured with a 14-position carousel and equipped with pressure and temperature sensors. After digestion and cooling to approximately 30°C, the samples were kept frozen in polycarbonate containers at −20°C until analysis. Lastly, iron quantification was carried out using an Analytik Jena ContrAA 700 high-resolution continuum source flame atomic absorption spectrometer (Analytik Jena, Jena, Germany) equipped with a xenon short-arc lamp XBO 301 (GLE, Berlin, Germany) with a nominal power of 300 W operating in a hot spot mode as a continuum radiation source. Iron was analyzed at 248.3270 nm by using the Graphite Furnace module equipped with an MPE60 autosampler (Analytik Jena) and argon 5.0 purity grade (Linde, Munich, Germany) as the inert gas. Transversal and pyrolytically coated graphite tubes with integrated platforms were used. In order to obtain maximum absorbance and minimum background values, operational parameters were optimized and are presented in Table S4. External calibration curves were daily constructed based on at least six standard solutions of iron prepared from 1,000 mg/liter stock solutions (Panreac Quimica SA, Barcelona, Spain). Magnesium nitrate hexahydrate (traceable to standard reference material [SRM] from National Institute of Standards and Technology [NIST]; Merck) was used as a matrix modifier at 0.1% (wt/vol). All glassware and plastic material were soaked in nitric acid (50% vol/vol), thoroughly rinsed with ultrapure water, and dried before use. The instrument performance was checked using analytical blanks and standards analyzed daily and regularly along with samples. The results were normalized to the cell dry weight.
Detection of siderophore production.
Bacterial cultures were prepared as described above, except that the incubation period in CDM(Fe−) was 72 h for induction of maximal siderophore production. Afterwards, the cultures were harvested by centrifugation at 5,000 × g, for 10 min at 4°C. Culture supernatants were collected and filter-sterilized (pore size, 0.2 μm) for analysis of siderophore production using a modified Chrome Azurol S (CAS) agar diffusion assay as previously described (42).
Planktonic growth curves.
Two-mL of cultures grown overnight in TSB were harvested by centrifugation at 5,000 × g for 10 min. The cells were washed twice in 0.9% (wt/vol) NaCl and diluted into CDM(Fe−) to an OD640 of 0.025 (∼107 CFU·mL−1) in a conical glass flask. Flasks were incubated at 37°C, 120 rpm (ES-20 Shaker-Incubator). OD640 was measured hourly up to 8 h and also at 24 h of incubation (when appropriate, concentrated samples were diluted in CDM(Fe−) for accurate measurement). Three independent experiments were performed for each condition tested.
Biofilm formation assays.
Biofilms were grown either on 96-well microplates made of polystyrene plastic (Orange Scientific, Braine-l’Alleud, Belgium) for quantification of biofilm biomass or on Lab-Tek chamber slide system 8-well Permanox slides (Thermo Fisher Scientific Inc.) for confocal microscopy analysis. The cultures were prepared as described above, diluted into CDM(Fe−) to an OD640 of 0.25 (∼108 CFU/mL), and further diluted 1:100 into (i) CDM(Fe−), (ii) CDM(Fe+), or (iii) TSB. Afterwards, diluted bacterial suspensions were placed into the microplates/chamber slides and incubated for 24 h at 37°C under static conditions.
Quantification of biofilm biomass.
Biofilms formed on 96-well microtiter plates were used for biomass quantification. After incubation, culture supernatants were removed carefully, and biofilms were washed twice with 200 μl of 0.9% NaCl and then stained by crystal violet technique, as previously described (43). Experiments were run at least in triplicate with technical quadruplicates for each condition tested.
Confocal laser scanning microscopy analysis.
Biofilms formed on the chamber slide system were analyzed through confocal laser scanning microscopy (CLSM). After incubation, the culture supernatants were removed carefully, and the biofilms were washed twice with 200 μl of 0.9% NaCl and then stained with (i) DAPI (4′,6-diamidino-2-phenylindole) nucleic acid stain (Sigma-Aldrich) for visualization of cells and (ii) wheat germ agglutinin (WGA) conjugated with Texas Red (Thermo Fisher Scientific, Inc.) for staining of N-acetylglucosaminyl residues (PIA/PNAG). All staining procedures were performed according to the manufacturer’s instructions. Stained biofilms were visualized as previously described (19).
Gene expression analysis.
RNA samples were obtained from S. epidermidis cells cultured in CDM(Fe−) for 24 h. RNA extraction, DNase treatment and RNA quality determination were performed as previously described (19). cDNA synthesis was performed using the RevertAid first strand cDNA synthesis kit (Thermo Fisher Scientific, Inc.) following the manufacturer’s instructions. The same amount of total RNA (300 ng) from each sample was reverse transcribed in a 10-μl reaction volume using random hexamer (or gene-specific) primers as priming strategy. To determine the possibility of genomic DNA carryover, control reactions were performed under the same conditions but lacking the reverse transcriptase enzyme (NRT control). All RNA samples extracted were absent of significant genomic DNA. Gene expression was determined by qPCR using Xpert iFast SYBR Mastermix (GRiSP, Lda., Porto, Portugal). Each PCR contained 2 μl of 1:200 diluted cDNA or NRT control, 5 μl of master mix, 1 μl of primer mixture (in the final reaction, each primer was at 0.3 μM), and 2 μl of nuclease-free water. qPCR runs were performed on a CFX 96 (Bio-Rad) with the following cycle parameters: 95°C for 3 min and 40 cycles of 95°C for 5 s and 60°C for 25 s. Melt analysis was performed at the end to ensure the absence of unspecific products and primer dimer. All genes were quantified in duplicate for biological triplicates. The expression of the genes tested was normalized to the expression of the reference gene 16S rRNA. The data were log transformed (Log2) before statistical analysis was performed. Information about the primers used in this study is listed in Table S2. Primers were designed with the aid of Primer3 (44) using S. epidermidis 1457 genome sequence (NCBI accession no. CP020463.1) as the template. mFold was used for prediction of secondary structures (45). No secondary structures were found for the operating temperatures used. Gene specificity of all primers was confirmed using Primer-BLAST (46). PCR amplification efficiency (E) for each gene has been previously determined (19).
Isolation of peripheral blood mononuclear cells (PBMCs).
Human samples were obtained in agreement with the principles of the Declaration of Helsinki. PBMCs were isolated from surplus buffy coats, kindly provided by the Immunohemotherapy Department of Centro Hospitalar São João (CHSJ), Porto, Portugal. The procedures were approved by the Hospital Ethical Committee (protocol 90/19). Informed written consent that the by-products of their blood collections could be used for research purposes was obtained from the blood donors. The blood was diluted 1:2 in DPBS (Dulbecco’s phosphate-buffered saline, without calcium and magnesium; Sigma-Aldrich), and 6 mL were carefully layered onto 3-mL Histopaque-1077 (Sigma-Aldrich) and centrifuged (400 × g, 30 min, room temperature, break-off) (Heraeus Megafuge 1.0R, Heraeus, Hanau, Germany). The PBMC layer was carefully transferred into a clean conical centrifuge tube and washed with DPBS. The cell pellet was recovered in DPBS, and cell concentration was determined.
Monocyte purification by magnetic-activated cell sorting.
Monocytes were purified from previously prepared PBMC suspensions using CD14 MicroBeads, human kit (Miltenyi Biotec, Bergisch Gladbach, Germany), and MS columns (Miltenyi Biotec) in a Mini MACS separator (Miltenyi Biotec), according to manufacturer’s instructions. The obtained CD14+ cells were counted using a hemocytometer.
Macrophage differentiation.
Monocytes (CD14+ cells) were plated in either 6-, 24-, or 96-well cell culture plates (Nunclon Delta Surface; Thermo Fisher Scientific Inc.) in complete RPMI medium (cRPMI) (RPMI 1640 medium supplemented with 10 mM HEPES buffer, 2 mM l-glutamine, 100 U/mL penicillin/streptomycin, 0.05 mM β-mercaptoethanol, all from Sigma-Aldrich), 5% (vol/vol) heat-inactivated fetal bovine serum (FBS; Biowest, Riverside, MO) or autologous plasma (where indicated). The cells were seeded at the appropriate concentration and incubated at 37°C in a humidified atmosphere and 5% CO2. To generate human monocyte-derived macrophages (hMDM) skewed toward an M1- or M2-like profile, cRPMI medium was supplemented with either 25 ng/mL of macrophage colony-stimulating factor (M-CSF; R&D Systems, Minneapolis, MN) or 25 ng/mL of granulocyte macrophage colony-stimulating factor (GM-CSF; PeproTech, Rocky Hill, NJ), respectively. Half of the culture medium was replaced at days 3 and 6 of culture by fresh, prewarmed M-CSF or GM-CSF supplemented cRPMI medium, as adequate. Experiments using hMDM were performed with cells prepared from three different donors.
RAW264.7 cell cultures.
Murine RAW264.7 macrophages (ATCC TIB-71) were grown in cRPMI and incubated at 37°C in a humidified atmosphere and 5% CO2. The used cells underwent less than 10 passages. After this point, new cells were revived from frozen stocks.
Infection of macrophages: gentamicin protection assays.
Suspensions of S. epidermidis wt and its isogenic mutants were prepared as described above and used to infect previously plated RAW264.7 (5 × 105 cells/well) or hMDM (1 × 105 cells/well) in 96-well plates at an multiplicity of infection (MOI) of 10:1. To synchronize phagocytosis, the plates were centrifuged at 300 × g for 2 min followed by incubation at 37°C in the presence of 5% CO2. Macrophages were allowed to internalize bacteria for 30 min. Afterwards, the culture supernatants were discarded, and prewarmed serum-free cRPMI plus 50 μg/mL gentamicin (AppliChem, Darmstadt, Germany) was added for 60 min to eliminate extracellular bacteria. After this treatment, macrophages were rinsed with DPBS and further incubated in prewarmed antibiotic-free cRPMI for the desired period of time (0, 2, 6, 12, and 24 h). Release of the gentamicin-protected bacteria (which corresponds to the intracellular fraction) was performed by lysing macrophages with 0.1% (wt/vol) saponin (Sigma-Aldrich) in PBS for 15 min. In order to eliminate bacterial aggregates, lysates underwent sonication (three cycles of 10 s at 30% amplitude using a Branson W140 Sonifier, Danbury, CT). Lastly, lysates were serially diluted in PBS and plated onto TSA plates for CFU enumeration.
Survival in whole human blood.
Survival in whole human blood was carried out using an ex vivo human blood model of bloodstream infection (5). Human blood was collected in heparin tubes (Vacuette, GreinerBio-One GmbH, Austria) from seven healthy volunteers. The blood was collected under a protocol approved by the Institutional Review Board of the University of Minho (SECVS 002/2014 [ADENDA]), which is in strict accordance with the Declaration of Helsinki and Oviedo Convention. All donors gave written informed consent to have blood taken. Cultures were prepared as described above, diluted into CDM(Fe−) to an OD640 of 0.25 (∼108 CFU/mL), and further diluted in PBS to ∼106 CFU/mL. Finally, 50 μl of the bacterial suspension was mixed with 450 μl of blood in 2-mL microtubes. The mixture was incubated 0, 2, and 4 h at 37°C and 5% CO2 with orbital rotation (80 rpm) and then serially diluted in PBS and plated onto TSA plates. Bacterial survival was assessed from the ratio between CFU counts at time points 2 and 4 h and those at 0 h. The data were log transformed (Log2) before statistical analysis was performed (full details available in the supplemental material).
Murine model of S. epidermidis bacteremia.
BALB/c mice were purchased from Charles River (Barcelona, Spain) and kept under specific pathogen-free conditions at the Animal Facility of the Instituto de Investigação e Inovação em Saúde (i3S; Porto, Portugal). Procedures involving mice were performed according to the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS 123), directive 2010/63/EU of the European parliament and of the council of 22 September 2010 on the protection of the animals used for scientific purposes, and Portuguese rules (DL 113/2013). The experiments were approved by the institutional board responsible for animal welfare (ORBEA) at i3S, and authorization to perform the experiments was issued by the competent national authority (Direcção Geral de Alimentação e Veterinária; reference number 014036/2019-07-24). In vivo infection experiments were performed following biosafety level 2 (BSL-2) guidelines. BALB/c mice were infected intravenously with ∼5 × 108 CFU of S. epidermidis 1457 or its isogenic siderophore biosynthetic (Δsfa) and iron uptake (Δhts and ΔfhuC) mutants. Six hours after infection, the mice were euthanized; blood, liver, kidneys, and spleen were aseptically collected, weighed, and homogenized; and bacterial burden were determined by plating for CFU counts on TSA. The data were obtained from two independent experiments.
Sequence analysis.
DNA sequences were retrieved from the available genome of S. epidermidis 1457 (NCBI accession no. CP020463). Identification of putative Fur boxes was performed with the FIMO tool (47), using the default parameters and the 19-bp Fur box consensus sequence 5′-GATAATGATAATCATTATC-3′ (48) as the input motif. antiSMASH 5.1.0 was used for identification and analysis of secondary metabolite biosynthesis gene clusters (49). Synteny conservation was studied in all available S. epidermidis genomes using SyntTax (50).
Statistical analysis.
Statistical significance was determined using GraphPad Prism version 7.0a. The statistical tests used, significance values, and group sizes are described in the figure legends. Significance was defined as P < 0.05, and data were excluded only on the basis of technical errors associated with the experiment.
Supplementary Material
ACKNOWLEDGMENTS
We acknowledge the assistance of Nurse Filomena and thank all the blood donors.
N.C. and M.V. acknowledge the support by the Portuguese Foundation for Science and Technology (FCT) through the funded project PTDC/BIAMOL/29553/2017, under the scope of COMPETE2020 (POCI-01-0145-FEDER-029553). N.C. acknowledges the strategic funding of UID/BIO/04469/2019 unit by FCT. M.V. acknowledge the support of the i3S Scientific Platform HEMS, member of the Portuguese Platform of BioImaging (PPBI) (PPBIPOCI-01-0145-FEDER-022122), funded by FCT. H.R. acknowledges support from the German Research Council (DFG Ro 2413/4-1), the Damp Foundation (2013-19), and the Joachim Herz Foundation. F.O. was supported by an individual Ph.D. scholarship (SFRH/BD/101399/2014).
F.O., M.V., H.R., and N.C. designed research; F.O., T.L., A.M.S., and C.S. performed research; S.M. contributed new reagents/analytic tools; F.O., T.L., A.C., C.S., S.M., and S.W. analyzed data; M.V., H.R., and N.C. supervised research; and F.O., M.V., H.R., and N.C. wrote the paper. All authors read and approved the final version of the manuscript.
Footnotes
Supplemental material is available online only.
Contributor Information
Nuno Cerca, Email: nunocerca@ceb.uminho.pt.
Hermine V. Mkrtchyan, University of West London
REFERENCES
- 1.Allegranzi B, Nejad SB, Combescure C, Graafmans W, Attar H, Donaldson L, et al. 2011. Report on the burden of endemic health care-associated infection worldwide. World Health Organization, Geneva, Switzerland. [DOI] [PubMed] [Google Scholar]
- 2.Widerström M. 2016. Significance of Staphylococcus epidermidis in health care-associated infections, from contaminant to clinically relevant pathogen: this is a wake-up call! J Clin Microbiol 54:1679–1681. doi: 10.1128/JCM.00743-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lee JYH, Monk IR, Gonçalves da Silva A, Seemann T, Chua KYL, Kearns A, Hill R, Woodford N, Bartels MD, Strommenger B, Laurent F, Dodémont M, Deplano A, Patel R, Larsen AR, Korman TM, Stinear TP, Howden BP. 2018. Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis. Nat Microbiol 3:1175–1185. doi: 10.1038/s41564-018-0230-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kleinschmidt S, Huygens F, Faoagali J, Rathnayake IU, Hafner LM. 2015. Staphylococcus epidermidis as a cause of bacteremia. Future Microbiol 10:1859–1879. doi: 10.2217/fmb.15.98. [DOI] [PubMed] [Google Scholar]
- 5.França A, Carvalhais V, Maira-Litrán T, Vilanova M, Cerca N, Pier G. 2014. Alterations in the Staphylococcus epidermidis biofilm transcriptome following interaction with whole human blood. Pathog Dis 70:444–448. doi: 10.1111/2049-632X.12130. [DOI] [PubMed] [Google Scholar]
- 6.Monk IR, Foster TJ. 2012. Genetic manipulation of staphylococci – breaking through the barrier. Front Cell Infect Microbiol 2:49. doi: 10.3389/fcimb.2012.00049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Cassat JE, Skaar EP. 2013. Iron in infection and immunity. Cell Host Microbe 13:509–519. doi: 10.1016/j.chom.2013.04.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Andrews SC, Robinson AK, Rodríguez-Quiñones F. 2003. Bacterial iron homeostasis. FEMS Microbiol Rev 27:215–237. doi: 10.1016/S0168-6445(03)00055-X. [DOI] [PubMed] [Google Scholar]
- 9.Köster W. 2001. ABC transporter-mediated uptake of iron, siderophores, heme and vitamin B12. Res Microbiol 152:291–301. doi: 10.1016/S0923-2508(01)01200-1. [DOI] [PubMed] [Google Scholar]
- 10.Wilson BR, Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y. 2016. Siderophores in iron metabolism: from mechanism to therapy potential. Trends Mol Med 22:1077–1090. doi: 10.1016/j.molmed.2016.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Beasley FC, Marolda CL, Cheung J, Buac S, Heinrichs DE. 2011. Staphylococcus aureus transporters Hts, Sir, and Sst capture iron liberated from human transferrin by staphyloferrin A, staphyloferrin B, and catecholamine stress hormones, respectively, and contribute to virulence. Infect Immun 79:2345–2355. doi: 10.1128/IAI.00117-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Perry WJ, Spraggins JM, Sheldon JR, Grunenwald CM, Heinrichs DE, Cassat JE, Skaar EP, Caprioli RM. 2019. Staphylococcus aureus exhibits heterogeneous siderophore production within the vertebrate host. Proc Natl Acad Sci USA 116:21980–21982. doi: 10.1073/pnas.1913991116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Beasley FC, Vinés ED, Grigg JC, Zheng Q, Liu S, Lajoie GA, Murphy MEP, Heinrichs DE. 2009. Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus. Mol Microbiol 72:947–963. doi: 10.1111/j.1365-2958.2009.06698.x. [DOI] [PubMed] [Google Scholar]
- 14.Cotton JL, Tao J, Balibar CJ. 2009. Identification and characterization of the Staphylococcus aureus gene cluster coding for staphyloferrin A. Biochemistry 48:1025–1035. doi: 10.1021/bi801844c. [DOI] [PubMed] [Google Scholar]
- 15.Kobylarz MJ, Grigg JC, Takayama SIJ, Rai DK, Heinrichs DE, Murphy MEP. 2014. Synthesis of l-2,3-diaminopropionic acid, a siderophore and antibiotic precursor. Chem Biol 21:379–388. doi: 10.1016/j.chembiol.2013.12.011. [DOI] [PubMed] [Google Scholar]
- 16.Cooper JD, Hannauer M, Marolda CL, Briere LAK, Heinrichs DE. 2014. Identification of a positively charged platform in Staphylococcus aureus HtsA that is essential for ferric staphyloferrin A transport. Biochemistry 53:5060–5069. doi: 10.1021/bi500729h. [DOI] [PubMed] [Google Scholar]
- 17.Madsen JLH, Johnstone TC, Nolan EM. 2015. Chemical synthesis of staphyloferrin B affords insight into the molecular structure, iron chelation, and biological activity of a polycarboxylate siderophore deployed by the human pathogen Staphylococcus aureus. J Am Chem Soc 137:9117–9127. doi: 10.1021/jacs.5b04557. [DOI] [PubMed] [Google Scholar]
- 18.Dale SE, Sebulsky MT, Heinrichs DE. 2004. Involvement of SirABC in iron-siderophore import in Staphylococcus aureus. J Bacteriol 186:8356–8362. doi: 10.1128/JB.186.24.8356-8362.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Oliveira F, França Â, Cerca N. 2017. Staphylococcus epidermidis is largely dependent on iron availability to form biofilms. Int J Med Microbiol 307:552–563. doi: 10.1016/j.ijmm.2017.08.009. [DOI] [PubMed] [Google Scholar]
- 20.Oliveira F, Lima T, Correia A, Silva AM, Morais C, Morais S. 2021. Siderophore-mediated iron acquisition plays a critical role in biofilm formation and survival of Staphylococcus epidermidis within the host. Front Med, in press. doi: 10.3389/fmed.2021.799227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Flannagan RS, Cosío G, Grinstein S. 2009. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 7:355–366. doi: 10.1038/nrmicro2128. [DOI] [PubMed] [Google Scholar]
- 22.Gan Z, Tang X, Wang Z, Li J, Wang Z, Du H. 2019. Regulation of macrophage iron homeostasis is associated with the localization of bacteria. Metallomics 11:454–461. doi: 10.1039/C8MT00301G. [DOI] [PubMed] [Google Scholar]
- 23.Schommer NN, Christner M, Hentschke M, Ruckdeschel K, Aepfelbacher M, Rohde H. 2011. Staphylococcus epidermidis uses distinct mechanisms of biofilm formation to interfere with phagocytosis and activation of mouse macrophage-like cells J774A.1. Infect Immun 79:2267–2276. doi: 10.1128/IAI.01142-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Liu Q, Liu Q, Meng H, Lv H, Liu Y, Liu J, Wang H, He L, Qin J, Wang Y, Dai Y, Otto M, Li M. 2020. Staphylococcus epidermidis contributes to healthy maturation of the nasal microbiome by stimulating antimicrobial peptide production. Cell Host Microbe 27:68–78.e5. doi: 10.1016/j.chom.2019.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Boelens JJ, Dankert J, Murk JL, Weening JJ, van der Poll T, Dingemans KP, Koole L, Laman JD, Zaat SA. 2000. Biomaterial‐associated persistence of Staphylococcus epidermidis in pericatheter macrophages. J Infect Dis 181:1337–1349. doi: 10.1086/315369. [DOI] [PubMed] [Google Scholar]
- 26.Riool M, de Boer L, Jaspers V, van der Loos CM, van Wamel WJB, Wu G, Kwakman PHS, Zaat SAJ. 2014. Staphylococcus epidermidis originating from titanium implants infects surrounding tissue and immune cells. Acta Biomater 10:5202–5212. doi: 10.1016/j.actbio.2014.08.012. [DOI] [PubMed] [Google Scholar]
- 27.Perez K, Patel R. 2018. Survival of Staphylococcus epidermidis in fibroblasts and osteoblasts. Infect Immun 86:e00237-18. doi: 10.1128/IAI.00237-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Mazmanian SK, Skaar EP, Gaspar AH, Humayun M, Gornicki P, Jelenska J, Joachmiak A, Missiakas DM, Schneewind O. 2003. Passage of heme-iron across the envelope of Staphylococcus aureus. Science 299:906–909. doi: 10.1126/science.1081147. [DOI] [PubMed] [Google Scholar]
- 29.Torres VJ, Pishchany G, Humayun M, Schneewind O, Skaar EP. 2006. Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J Bacteriol 188:8421–8429. doi: 10.1128/JB.01335-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Dumas Z, Ross-Gillespie A, Kümmerli R. 2013. Switching between apparently redundant iron-uptake mechanisms benefits bacteria in changeable environments. Proc Biol Sci 280:20131055. doi: 10.1098/rspb.2013.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Garcia EC, Brumbaugh AR, Mobley HLT. 2011. Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun 79:1225–1235. doi: 10.1128/IAI.01222-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Oliveira F, Rohde H, Vilanova M, Cerca N. 2021. The emerging role of iron acquisition in biofilm-associated infections. Trends Microbiol 29:772–775. doi: 10.1016/j.tim.2021.02.009. [DOI] [PubMed] [Google Scholar]
- 33.Pelegrin P, Barroso-Gutierrez C, Surprenant A. 2008. P2X 7 receptor differentially couples to distinct release pathways for IL-1β in mouse macrophage. J Immunol 180:7147–7157. doi: 10.4049/jimmunol.180.11.7147. [DOI] [PubMed] [Google Scholar]
- 34.Shimada T, Park BG, Wolf AJ, Brikos C, Goodridge HS, Becker CA, Reyes CN, Miao EA, Aderem A, Götz F, Liu GY, Underhill DM. 2010. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1β secretion. Cell Host Microbe 7:38–49. doi: 10.1016/j.chom.2009.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hanke ML, Heim CE, Angle A, Sanderson SD, Kielian T. 2013. Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections. J Immunol 190:2159–2168. doi: 10.4049/jimmunol.1202348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hussain M, Hastings JGM, White PJ. 1991. A chemically defined medium for slime production by coagulase-negative staphylococci. J Med Microbiol 34:143–147. doi: 10.1099/00222615-34-3-143. [DOI] [PubMed] [Google Scholar]
- 37.Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]
- 38.Geiger T, Francois P, Liebeke M, Fraunholz M, Goerke C, Krismer B, Schrenzel J, Lalk M, Wolz C. 2012. The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog 8:e1003016. doi: 10.1371/journal.ppat.1003016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Quan J, Tian J. 2011. Circular polymerase extension cloning for high-throughput cloning of complex and combinatorial DNA libraries. Nat Protoc 6:242–251. doi: 10.1038/nprot.2010.181. [DOI] [PubMed] [Google Scholar]
- 40.Bae T, Schneewind O. 2006. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55:58–63. doi: 10.1016/j.plasmid.2005.05.005. [DOI] [PubMed] [Google Scholar]
- 41.Winstel V, Kühner P, Rohde H, Peschel A. 2016. Genetic engineering of untransformable coagulase-negative staphylococcal pathogens. Nat Protoc 11:949–959. doi: 10.1038/nprot.2016.058. [DOI] [PubMed] [Google Scholar]
- 42.Shin SH, Lim Y, Lee SE, Yang NW, Rhee JH. 2001. CAS agar diffusion assay for the measurement of siderophores in biological fluids. J Microbiol Methods 44:89–95. doi: 10.1016/s0167-7012(00)00229-3. [DOI] [PubMed] [Google Scholar]
- 43.Stepanović S, Vuković D, Hola V, Di Bonaventura G, Djukić S, Cirković I, Ruzicka F. 2007. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115:891–899. doi: 10.1111/j.1600-0463.2007.apm_630.x. [DOI] [PubMed] [Google Scholar]
- 44.Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG. 2012. Primer3-new capabilities and interfaces. Nucleic Acids Res 40:e115. doi: 10.1093/nar/gks596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Zuker M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406–3415. doi: 10.1093/nar/gkg595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. 2012. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13:134. doi: 10.1186/1471-2105-13-134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Grant CE, Bailey TL, Noble WS. 2011. FIMO: scanning for occurrences of a given motif. Bioinformatics 27:1017–1018. doi: 10.1093/bioinformatics/btr064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.De Lorenzo V, Wee S, Herrero M, Neilands JB. 1987. Operator sequences of the aerobactin operon of plasmid ColV-K30 binding the ferric uptake regulation (fur) repressor. J Bacteriol 169:2624–2630. doi: 10.1128/jb.169.6.2624-2630.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Blin K, Shaw S, Steinke K, Villebro R, Ziemert N, Lee SY, Medema MH, Weber T. 2019. antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline. Nucleic Acids Res 47:W81–W87. doi: 10.1093/nar/gkz310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Oberto J. 2013. SyntTax: a web server linking synteny to prokaryotic taxonomy. BMC Bioinformatics 14:4. doi: 10.1186/1471-2105-14-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental material. Download SPECTRUM02168-21_Supp_1_seq8.pdf, PDF file, 2.8 MB (2.9MB, pdf)